Frequently Asked Questions
Factors such as increased cases of whooping cough is acting as the major drivers for the global pertussis market.
Merck KGaA (Germany), Novartis AG (Switzerland) , Mylan N.V. (U.S.), Teva Pharmaceutical Industries Ltd. (Israel), Sanofi (France), Novartis AG (Switzerland), Sun Pharmaceutical Industries Ltd. (India), Aurobindo Pharma (India), GSK plc (U.K.), F. Hoffmann-La Roche Ltd. (Switzerland), AstraZeneca (U.K.), Lilly (U.S.).
The major countries covered in the Pertussis Market are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
